Early stage partnerships Erimos focuses on small molecule therapeutics for cancer and viral diseases with a small team, making them an attractive partner for pharma/biotech seeking nimble co-development or licensing for early discovery and preclinical programs.

CRO and CMO With a lean footprint and a sub-1M revenue profile, Erimos presents a compelling case for outsourced discovery, assay development, and early-scale manufacturing collaborations, leveraging regional CRO/CMO networks to accelerate programs.

Funding and growth The current pre-revenue to low-revenue stage signals potential interest from non-dilutive funding sources (e.g., SBIR/STTR), venture co-development deals, or strategic licensing to fuel pipeline expansion.

Digital collaboration Their modern web technology stack suggests receptivity to partnerships that require secure data sharing, collaboration tools, and compliant digital communications to accelerate deal workflows with investors and collaborators.

Regional access Located in Raleigh, NC with proximity to the Research Triangle Park, Erimos can capitalize on local academic collaborations, university tech transfer offices, and regional biotech networks to support discovery programs and talent recruitment.